Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.8700 (-0.57%) ($20.3400 - $21.6100) on Fri. Apr. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.58% (three month average) | RSI | 53 | Latest Price | $20.8700(-0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.29% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-9%) UNG(-3%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.29% (StdDev 6.58%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $20.83(0.19%) | 10 Day Moving Average | $20.85(0.1%) | 20 Day Moving Average | $20.39(2.35%) | To recent high | -8.6% | To recent low | 49% | Market Cap | $1.551b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |